Novorex
PrivateLast Round
Series B
Apr 9, 2026
Est. Valuation
$41.08M
Total Funding Raised
$33.45M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Novorex is a biotechnology company that develops small-molecule drugs for cancer and central nervous system diseases using an AI-driven, fragment-based drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Warehouse Automation, Pharma Supply Chain, Supply Chain Tracking
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novorex Comparables
Compare Novorex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ScriptPro | 79% | |
| ARxIUM | 78% | |
| JVM Co., Ltd. | 78% | |
Novorex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 9, 2026 | ||||
| Series A Extension | Nov 21, 2023 | ||||
| Series A | Jul 1, 2021 | ||||
| Pre Seed | Feb 1, 2020 |
Novorex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hana Ventures | Series A Extension |
| KOTEC | Series A Extension |
| BNH INVESTMENT | Series A Extension |
| Hyundai Venture Investment Corporation | Series B |
| UTC Investment | Series B, Series A Extension |
| KB Investment | Series B, Series A Extension |
| Samsung Securities | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
$14.1M round with participation from KB Securities and Hyundai Venture Investment Corporation.
- Nov 21, 2023
Raised $9M from UTC Investment, BNH Investment, and others.
Novorex Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Novorex's valuation, stock price, and market status.